Section 105.02. Definitions.

  In this chapter:

(1)  "Administering agency" has the meaning given in s. 49.162 (1) (a) , Stats.

(2)  "Confirmation test" means an analytical procedure used to quantify a specific controlled substance or its metabolite in a specimen through a test that is different in scientific principle from that of the initial test procedure and capable of providing requisite specificity, sensitivity, and quantitative accuracy to positively determine use of a controlled substance.

(3)  "Controlled substance" or "substance" has the meaning given for "controlled substance" in s. 961.01 (4) , Stats.

(4)  "Department" means the department of children and families.

(5)  "Individual" means a person who has applied to participate in a work experience program or a person who has been determined eligible for the program and is participating in program activities or awaiting assignment to program activities.

(6)  "Medical review officer" means a licensed physician employed by or providing services under contract to a drug testing vendor who has knowledge of substance abuse disorders and laboratory testing procedures and who has the necessary training and experience to interpret and evaluate an individual's positive test result in relation to the individual's medical history and current, valid prescriptions.

(7)  "Metabolite" means a chemical present in the body when a controlled substance is being broken down through natural metabolic processes that can be detected or measured as a positive indicator that a controlled substance associated with the metabolite has been used.

(8)  "Reasonable suspicion" means suspicion of controlled substance abuse by an individual based on that individual's score on a screening questionnaire.

(9)  "Screening" means completion of a questionnaire regarding the individual's current and prior use of controlled substances.

(10)  "Specimen" means tissue, fluid, or a product of the human body capable of revealing the presence of controlled substances or their metabolites.

(11)  "Treatment" means services that are conducted under clinical supervision to assist an individual through the process of recovery from controlled substance abuse and may include screening, application of approved placement criteria, intake, orientation, assessment, individualized treatment planning, intervention, individual or group and family counseling, referral, discharge planning, after care or continuing care, recordkeeping, consultation with other professionals regarding the patient's treatment services, recovery and case management, crisis intervention, client education, employment, and problem resolution in life skills functioning.

(12)  "Treatment program" means a program certified to provide treatment for controlled substance abuse as a medically managed inpatient service under s. DHS 75.10 , a medically monitored treatment service under s. DHS 75.11 , a day treatment service under s. DHS 75.12 , an outpatient treatment service under s. DHS 75.13 , a transitional residential treatment service under s. DHS 75.14 , or a narcotic treatment service for opiate addiction under s. DHS 75.15 .

(13)  "Treatment provider" or "provider" means a provider of treatment services for controlled substance abuse certified by the department of health services under the provisions of ch. DHS 75 .

(14)  "Work experience program" or "program" in this chapter means a work experience program providing services and benefits to noncustodial parents under s. 49.159 (1) (b) , Stats.; the Transform Milwaukee Jobs program under s. 49.163 , Stats.; or the Transitional Jobs program under s. 49.163 , Stats.

History: EmR1523 : emerg. cr., eff. 11-9-15; CR 15-091 : cr. Register June 2016 No. 726 , eff. 7-1-16; correction in numbering of (6), (7), (14) made under s. 13.92 (4) (b) 1. , Stats., Register June 2016 No. 726 .